Literature DB >> 6450603

In vitro generation of lymphocytotoxicity to autochthonous leukaemic cells in chronic myeloid leukaemia.

A G Khare, S H Advani, S G Gangal.   

Abstract

Lymphocytes from 13 chronic myeloid leukaemia (CML) patients in remission were tested for their ability to differentiate in vitro into a cell population cytotoxic to autochthonous target leukaemic cells. CML remission lymphocytes were cultured in vitro with autochthonous leukaemic cells and allogeneic normal lymphocytes from an unrelated donor, singly or in combination. The cytotoxic lymphocytes obtained after 7 days of culture were tested for their ability to kill autochthonous leukaemic cells in a 3h 51Cr-release assay. It was found that with the allogeneic stimulus alone, cytotoxicity was generated in 5/13 cases, whilst stimulation of lymphocytes with autochthonous leukaemic cells alone induced cytotoxicity in 7/13 cases. In contrast, anti-leukaemic cytotoxicity was shown in 12/13 cases when responder lymphocytes were stimulated with both autochthonous leukaemic and unrelated allogeneic normal lymphocytes. The specificity of cytotoxicity was confirmed using other targets such as autochthonous PHA-transformed lymphoblasts and mouse L1210 cells. In 1/5 cases, CML remission lymphocytes stimulated with autochthonous leukaemic cells showed cytotoxicity to PHA-transformed autochthonous normal lymphoblasts, whilst 1/4 patients showed nonspecific cytotoxicity to L1210 cells when lymphocytes were cultured in MLC or MLTC, as well as in a 3-cell assay.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6450603      PMCID: PMC2010486          DOI: 10.1038/bjc.1981.3

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells.

Authors:  J M Zarling; P C Raich; M McKeough; F H Bach
Journal:  Nature       Date:  1976-08-19       Impact factor: 49.962

Review 2.  Leukaemia antigens and immunity in man.

Authors:  R Harris
Journal:  Nature       Date:  1973-01-12       Impact factor: 49.962

3.  51 Chromium-release assay for cell-mediated cytotoxicity of human leukemia and lymphoid tissue-culture cells.

Authors:  J L McCoy; R B Herberman; E B Rosenberg; F C Donnelly; P H Levine; C Alford
Journal:  Natl Cancer Inst Monogr       Date:  1973-06

4.  Immune reactivity of leukemia patients to autologous blast cells.

Authors:  B G Leventhal; R H Halterman; E B Rosenberg; R B Herberman
Journal:  Cancer Res       Date:  1972-09       Impact factor: 12.701

5.  Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins.

Authors:  E B Rosenberg; R B Herberman; P H Levine; R H Halterman; J L McCoy; J R Wunderlich
Journal:  Int J Cancer       Date:  1972-05-15       Impact factor: 7.396

6.  Cell-mediated destruction of human leukemic cells by MHC identical lymphocytes: requirement for a proliferative trigger in vitro.

Authors:  P M Sondel; C O'Brien; L Porter; S F Schlossman; L Chess
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

7.  Leukocyte migration studies in chronic myeloid leukemia (CML). Specificity of reactions.

Authors:  B P Gothoskar; H D'Silva; H Gharpure; S H Advani
Journal:  Eur J Cancer       Date:  1976-10       Impact factor: 9.162

8.  Antigens shared by leukemic blast cell and lymphoblastoid cell lines detected by lymphocyte-dependent antibody.

Authors:  A Durantez; J Zighelboim; T Thieme; J L Fahey
Journal:  Cancer Res       Date:  1975-10       Impact factor: 12.701

9.  Recognition of leukaemia cells as foreign before and after autoimmunization.

Authors:  R L Powles; L A Balchin; G H Fairley; P Alexander
Journal:  Br Med J       Date:  1971-02-27

10.  Demonstration of cellular immunity in chronic myeloid leukaemia using leucocyte migration inhibition assay.

Authors:  S G Gangal; B P Gothoskar; C S Joshi; S H Advani
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

View more
  5 in total

1.  Propagation of cytotoxic effectors from chronic myeloid leukemia patients and cloning of cytotoxic T cells.

Authors:  R Somasundaram; S H Advani; S G Gangal
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

2.  In vitro generation of effector cells cytotoxic to autologous targets from chronic myeloid leukemia patients in remission.

Authors:  R Somasundaram; S G Rao; S H Advani; S G Gangal
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

3.  Autologous responses to human leukaemic cells in mixed leucocyte culture.

Authors:  L K Ashman; D E O'Keefe; C A Juttner; I R Toogood; M S Rice
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  Concanavalin A induced suppressor cell activity and autorosette forming cells in chronic myeloid leukemia patients.

Authors:  R Somasundaram; S H Advani; S G Gangal
Journal:  Br J Cancer       Date:  1983-12       Impact factor: 7.640

5.  Treatment of fresh human leukaemia cells with actinomycin D enhances their lysability by natural killer cells.

Authors:  H W Ziegler-Heitbrock; J Erhardt; G Riethmüller
Journal:  Br J Cancer       Date:  1983-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.